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OBJECTIVES: The association between P wave dispersion and iron deficiency anemia has not been documented in
the literature. In this study, we evaluated P wave dispersion in patients with iron deficiency anemia and the possible
relationships between P wave dispersion and other echocardiographic parameters.
INTRODUCTION: The iron status of an individual may play an important role in cardiovascular health. Anemia is an
independent risk factor for adverse cardiovascular outcomes. P wave dispersion is a simple electrocardiographic marker
that has a predictive value for the development of atrial fibrillation. Apart from cardiovascular diseases, several conditions,
such as seasonal variation, alcohol intake and caffeine ingestion, have been demonstrated to affect P wave dispersion.
METHODS: The study included 97 patients who had iron deficiency anemia and 50 healthy subjects. The cases were
evaluated with a clinical examination and diagnostic tests that included 12-lead electrocardiography and
transthoracic echocardiography.
RESULTS: Compared to the control group, patients with iron deficiency anemia showed significantly longer maximum
P wave duration (Pmax) (91.1¡18.0 vs. 85.8¡6.7 msec, p = 0.054), P wave dispersion (PWD) (48.1¡7.7 vs. 40.9¡5.6
msec, p,0.001), mitral inflow deceleration time (DT) (197.5¡27.9 vs. 178.8¡8.9 msec, p,0.001) and isovolumetric
relaxation time (IVRT) (93.3¡9.2 vs. 77.4¡8.2 msec, p,0.001); they also showed increased heart rate (85.7¡16.1 vs.
69.0¡4.4, p,0.001) and frequency of diastolic dysfunction (7 (7.2%) vs. 0). Correlation analysis revealed that PWD was
significantly correlated with IVRT, DT, heart rate, the presence of anemia and hemoglobin level.
CONCLUSIONS: Iron deficiency anemia may be associated with prolonged P wave duration and dispersion and
impaired diastolic left ventricular filling.
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INTRODUCTION
P wave dispersion (PWD) is defined as the difference
between the longest and the shortest P-wave duration
recorded from multiple different surface ECG leads. To
date, the most extensive clinical evaluation of PWD has been
performed in the assessment of the risk for atrial fibrillation
(AF), which is characterized by inhomogeneous and
discontinuous atrial conduction. Several studies have
showed that PWD has a predictive value for the develop-
ment of AF in patients without apparent heart disease and
in patients who were hypertensive or had various cardiac
conditions.1-3 Apart from cardiovascular diseases, several
conditions such as seasonal variation, alcohol intake and
caffeine ingestion have been demonstrated to affect PWD.4-6
Anemia is an independent risk factor for adverse
cardiovascular outcomes.7,8 The iron status of an individual
may play an important role in cardiovascular health because
either an excess of iron or iron deficiency can lead to
significant problems.9 Increased risks of left ventricular (LV)
dilatation, systolic dysfunction, chronic heart failure and
death have been shown to be associated with a decrease in
hemoglobin (Hb) concentration of as little as 1 g/dL.10,11
To our knowledge, the association between PWD and iron
deficiency anemia (IDA) has not been documented in the
literature. In this study, we evaluated PWD in patients with
IDA and the possible relationships between PWD and other
echocardiographic parameters.
MATERIALS AND METHODS
In this study, 97 patients with IDA and 50 healthy controls
were included, and the following laboratory tests were
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conducted: complete blood count, peripheral smear, serum
ferritin, vitamin B12, folate, serum iron, iron binding
capacity and transferrin saturations. The diagnosis of iron
deficiency anemia was established as follows: hemoglobin
,12 g/dL in women and ,13 g/dL in men; serum ferritin
,12 ng/mL; and mean corpuscular volume (MCV) and
mean corpuscular hemoglobin concentration (MCHC)
values below the normal range (i.e., 83-97 fL and 32-36
g/dL, respectively).12
All study cases were evaluated with a detailed clinical
examination and diagnostic testing that included 12-lead
electrocardiography and transthoracic echocardiography.
Patients with the following conditions were excluded: acute
bleeding, chronic bleeding resulting from malignancy,
vitamin B12 or folate deficiency, thalassemia, sickle cell
disease, structural heart disease, ischemic heart disease,
diabetes, hypertension, renal failure, chronic obstructive
pulmonary disease, hypo- or hyperthyroidism and any
other systemic diseases. The subjects from the control group
were comparable to patients with iron deficiency anemia in
age, sex and body mass index, were free from any
cardiovascular disorder and were not taking any cardioac-
tive drugs. All subjects gave written informed consent to the
study, and the study was approved by the hospital ethics
committee in accordance with the Declaration of Helsinki.
Using a commercially available machine (Marquette Case,
Hellige Medical System, Cardiosmart, Hellige Instrument
Company, Freiburg, Germany) and with the patient in a
supine position, 12-lead ECGs with 20 mm/mV amplitude,
50 mm/sec rate and standard lead positions were obtained
after a 10-minute rest period. Using a magnifying glass, P
wave durations were manually measured by two cardiol-
ogists who had no information about the patients. The
beginning of the P wave was defined as the point at which
the initial deflection of the P wave crossed the isoelectric
line, and the end of the P wave was defined as the point at
which the final deflection of the P wave crossed the
isoelectric line. The difference between maximum and
minimum P wave duration (Pmax and Pmin, respectively)
was defined as PWD. Intra- and inter-observer coefficients
of the variation for P wave variables were insignificant at
less than 5%.
Using a commercially available echocardiographic device
(Vivid 3, General Electric) with a 3-MHz transducer, the
echocardiographic examination was performed with the
patient at rest in a left lateral decubitis position. Two
experienced echocardiographers, who were blinded to the
clinical data, conducted the examination. Using M-mode
echocardiography, long-axis measurements were obtained
at the level distal to the mitral valve leaflets according to
current recommendations.13 Left ventricular ejection frac-
tion (LVEF) was calculated via the modified biplane
Simpson’s method from apical four- and two-chamber
views. The pulsed Doppler sampling volume was placed
between the tips of the mitral valve leaflets to obtain
maximum filling velocities. Early diastolic flow (E), atrial
contraction signal (A) and E deceleration time (DT) were
measured. Isovolumetric relaxation time (IVRT) was deter-
mined as the interval between the end of the aortic outflow
and the start of the mitral inflow signal. Using the pulsed
wave spectral mode, Tissue Doppler Imaging (TDI) was
acquired to assess diastolic function. Filters and baselines
were corrected when the velocity ranged between -20 and
+20 cm/s. From the apical four-chamber view, a 5-mm
sample volume was placed at the lateral corner of the mitral
annulus. Early (Em) and late (Am) diastolic velocities as
well as the Em/Am ratio were calculated. All values were
measured on three separate beats and then averaged for all
parameters. During the entire echocardiographic study, a
single-lead electrocardiogram was continuously recorded.
Intra- and inter-observer coefficients of variation for
echocardiographic measurements were insignificant at less
than 10%. Impaired left ventricular relaxation was defined
as an Em/Am ratio ,1 and Ea ,10 cm/sec and/or all three
of the following: an E/A ratio ,1 (or , 0.5 for patients who
were .50 years old), DT . 200 msec and IVRT . 100 msec
(or .105 msec for patients who were .50 years old).14,15
Statistics
Quantitative variables are expressed as the mean ¡
standard deviation (SD), and qualitative variables are
expressed as numbers and percentages. Differences between
independent groups were assessed by t-tests for quantita-
tive data, the Chi-squared test for qualitative variables and
the Mann-Whitney’s U-test for variables without a normal
distribution. Using Pearson correlation analysis, the rela-
tionship between P wave variables and clinical and
echocardiographic variables were assessed. All tests were
performed using the SPSS program for Windows, version
10.0. A two-tailed p value of ,0.05 was considered
significant.
RESULTS
Baseline characteristics were not significantly different
between IDA patients and control subjects. Hemoglobin
levels among patients with IDA ranged between 4.7 and
10.0 g/dL. The etiologies for iron deficiency were as follows:
menorrhagia in 12 cases, ulcerated hiatus hernia in 13 cases,
peptic ulcer in 21 cases, hookworm infection in 4 cases,
hemorrhoidal bleeding in 15 cases, inflammatory bowel
disease in 3 cases, esophagitis in 8 cases, atrophic gastritis in
4 cases, diverticulosis in 5 cases, stomach surgery in 6 cases
and chronic blood donors in 6 cases. Mean heart rate, DT
and IVRT were significantly increased, and diastolic
dysfunction was significantly more frequent among IDA
patients (Table 1). Maximum P wave duration and PWD
were significantly longer in patients with IDA (Table 2).
PWD was significantly correlated with the following:
presence of anemia (r = 0.474, p,0.001), Hb level (r = -0.451,
p,0.001) (Figure 1), IVRT (r = 0.347, p,0.001), DT (r = 0.255,
p = 0.011) and heart rate (r = 0.252, p = 0.011). PWD was not
significantly correlated with any other clinical or echocar-
diographic parameters, including age, gender, LVEF and
systolic and diastolic blood pressure.
DISCUSSION
In this study, we found that P max and PWD were
significantly prolonged in patients with iron deficiency
anemia. In addition, the frequency of left ventricular
diastolic dysfunction was increased in IDA.
Se-veral studies have shown that PWD has a predictive
value for AF in patients with no underlying heart disease
and in those who are hypertensive and have various other
cardiac conditions.1-3 PWD is a simple electrocardiographic
marker that could be used for the prediction of paroxysmal
AF.3,16 Several factors have been shown to influence PWD.
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A seasonal variation has been demonstrated in healthy
subjects; specifically, PWD is shortest in the summer and
longest in the winter.17 Furthermore, the effects of obesity,
acute caffeine ingestion, alcohol intake and high altitude on
PWD in healthy subjects have been evaluated in several
studies, and differences between trained athletes and
control subjects have also been demonstrated.5,6,18-20
Therefore, it might be inappropriate to use a single PWD
measurement as a predictor of AF in healthy people because
PWD is influenced by many parameters, which may be risk
factors for the long-term development of AF. To our
knowledge, there is no study that has investigated the
effect of iron deficiency anemia on P wave measurements.
Compromised oxygen delivery capacity due to anemia
may result in chronic tissue hypoxemia, which may then
lead to myocyte dysfunction. Because iron moieties bind to
myoglobin, a total-body iron deficit could further impair the
ability of myocytes to extract oxygen from circulating
hemoglobin. Several mechanisms operate to compensate
for tissue hypoxia induced by anemia. When the hemoglo-
bin concentration drops below 10 g/dl or during non-
resting conditions, non-hemodynamic factors are sur-
mounted, and hemodynamic mechanisms begin to com-
pensate for tissue hypoxia.21 Although increased cardiac
output is the main hemodynamic factor and is mediated by
lower afterload, increased preload and positive inotropic
and chronotropic affects, the mechanisms of hemodynamic
compensation are complex. These mechanisms include (i) a
reduction in afterload due to a decrease in systemic vascular
resistance, (ii) an increase in preload due to an increase in
venous return and (iii) increased left ventricular (LV)
function attributed to increased sympathetic activity and
inotropic factors. In addition, heart rate is increased in
anemic patients due to hypoxia-stimulated chemorecep-
tors.22,23
In the present study, the frequency of LV diastolic
dysfunction was significantly increased in patients with
IDA. Several mechanisms may explain this association.
Tissue hypoxia induced by anemia may impair diastolic
function. Diastolic dysfunction without systolic dysfunction
may present at an early stage of myocardial ischemia, and
this is consistent with the finding that left ventricular
diastolic function is more susceptible to ischemia than
systolic function.24 Adaptation to an anemic state involves
the augmentation of heart rate, cardiac index, stroke work
and increased plasma volume.23,25 This overall increase in
sympathetic and inotropic activity places additional stress
on the myocardium and may lead to the remodeling of
myocytes and the vasculature. Anemia also has numerous
hormonal and metabolic effects that can result in direct
myocardial toxicity and ischemia.26 These specific effects
have been observed when the anemia is severe (Hb ,10 g/
dl). Therefore, subendocardial ischemia, increased heart rate
and altered loading conditions may contribute to the
anemia-associated diastolic dysfunction. LV diastolic dys-
function has also been shown to be associated with
increased PWD and may partially explain our finding of
increased PWD in IDA.27
P wave duration and PWD have also been reported to be
influenced by autonomic tone, which induces changes in the
velocity of impulse propagation. Increased sympathetic
activity causes a significant increase in PWD.28 Elevated
levels of norepinephrine in plasma and urine in IDA
patients support the role of increased sympathetic activity
in this effect.29 Low oxygen tension in the tissues may
explain the autonomic dysfunction in IDA. Hypoxia has an
important pathophysiological role in various diseases,
including anemia.30 Cardiac autonomic dysfunction has
been documented in various anemic patient populations,
such as those with vitamin B12 deficiency, sickle cell
anemia, thalassemia and iron deficiency anemia.31,32
Although it is unknown how low oxygen tension is detected
by cells, the influence of the carotid body on ventilatory and
cardiovascular reflexes seems to play a major role in altered
autonomic balance.33
Limitations
The most important limitation of our study is the manual
calculation of P-wave measurements using a magnifying
lens instead of computer-assisted P-wave calculations.
However, thermal, digital and signal-averaging ECG sys-
tems have been used to evaluate PWD, which was
measured manually either on paper or on a high-resolution
computer screen. Although several studies have demon-
strated a low error in the measurement of PWD on paper-
printed ECGs, other studies have suggested that manual
PWD measurement on paper-printed ECGs obtained at a
Table 1 - Comparison of clinical and echocardiographic
variables for patients with iron deficiency anemia versus
healthy subjects.
Parameters IDA (n = 97) Control (n = 50) P value
Age (years) 37.48¡11.9 37.28¡5.5 0.816
Male (n,%) 30 (30.9%) 13 (26%) 0.824
Body mass index (kg/m2) 23.3¡2.9 24.0¡1.8 0.194
Smoking (n,%) 20 (20.6%) 14 (28%) 0.483
Systolic BP (mmHg) 117.5¡9.3 118.0¡9.2 0.788
Diastolic BP (mmHg) 73.3¡8.3 73.3¡7.8 1.000
Hb (g/dl) 7.9¡1.6 14.2¡0.4 ,0.001
Htc (%) 25.3¡4.9 40.3¡1.7 ,0.001
LVDD (mm) 48.1¡4.2 47.7¡2.2 0.914
LVSD (mm) 30.8¡2.4 32.6¡2.1 0.462
LVEF (%) 63.0¡3.2 63.2¡2.2 0.385
IVS (mm) 9.3¡1.3 9.5¡0.6 0.297
PW (mm) 9.1¡1.2 9.4¡0.9 0.178
LA diameter (mm) 35.6¡4.5 34.4¡12.8 0.07
E/A 1.3¡0.3 1.3¡0.1 0.553
DT (msec) 197.5¡27.9 178.8¡8.9 ,0.001
IVRT (msec) 93.3¡9.2 77.4¡8.2 ,0.001
Diastolic dysfunction (n,%) 7 (7.2%) 0 0.012
SI (ug /dl) 19.50¡5.10 76.92¡23.60 0.001
Ferritin (ng/ml) 4.54¡3.51 42.55¡47.71 0.001
Transferrin saturation (%) 8.10¡2.18 34.23¡12.14 0.001
BP: Blood pressure, Hb: Hemoglobin, Htc: Hematocrit, LVDD: Left
ventricular diastolic diameter, LVSD: Left ventricular systolic diameter,
LVEF: Left ventricular ejection fraction, IVS: Interventricular septum, PW:
Posterior Wall, LA: Left atrium, DT: Deceleration time, IVRT: Isovolumetric
relaxation time, SI: Serum Iron.
Table 2 - Comparison of P wave variables and heart rate
for iron-deficient anemic patients versus healthy subjects.
IDA (n = 97) Control (n = 50) P value
Pmax (msec) 91.1¡18.0 85.8¡6.7 0.054
P min (msec) 44.8¡9.3 44.9¡9.1 0.957
PWD (msec) 48.1¡7.7 40.9¡5.6 ,0.001
Heart rate (bpm) 85.7¡16.1 69.0¡4.4 ,0.001
Pmax: Maximum P wave duration, Pmin: Minimum P wave duration, PWD:
P wave dispersion.
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standard signal size and paper speed may have question-
able accuracy and reproducibility.3,34 It is unclear whether
prolonged PWD may be associated with the long-term
development of AF. Pulsed wave Doppler indices used for
the evaluation of LV diastolic properties have been known
to be altered by numerous factors, including loading
conditions and heart rate, both of which can be altered by
anemia.35 However, to evaluate diastolic function, we also
used tissue Doppler indices, which are relatively indepen-
dent of loading conditions.
CONCLUSIONS
Iron deficiency anemia may be associated with prolonged
P wave duration and dispersion and impaired diastolic left
ventricular filling. Tissue hypoxia, altered loading condi-
tions and impaired autonomic balance with increased
sympathetic activity may be among the possible mechan-
isms that explain these findings.
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